|
| U.S. Brand
Names |
|
| Cyclomydril®
Ophthalmic |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
Phenylephrine and Cyclopentolate |

|
|
| Pharmacological Index |
|
|
Ophthalmic Agent, Antiglaucoma |

|
|
| Use |
|
|
Induce mydriasis greater than that produced with cyclopentolate HCl
alone |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Stability |
|
|
Store in tight containers and protect from light |

|
|
| Usual Dosage |
|
|
Ophthalmic: Neonates, Infants, Children, and Adults: Instill 1 drop into the
eye every 5-10 minutes, for up to 3 doses, approximately 40-50 minutes before
the examination |

|
|
| Administration |
|
|
Finger pressure should be applied to lacrimal sac for 1-2 minutes after
instillation to decrease risk of absorption and systemic
reactions |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
May cause blurred vision and increased sensitivity to
light |

|
|
| Dosage Forms |
|
|
Solution, ophthalmic: Cyclopentolate hydrochloride 0.2% and phenylephrine
hydrochloride 1% (2 mL, 5 mL) |

|
|
Copyright © 2007 Drugs Area
|